"The present study confirms that increased levels of 1CTP and P1NP concentrations are associated with presence of metastatic disease in the bone. Moreover, these markers are able to predict clinical course in PC patients with bone metastases."
tau.amegroups.org/article/v...
perplexity.ai/search/how-ar...
Wonder why these are not SOC tests, even if just before denosumab.